Sol-Gel Technologies Ltd(NASDAQ:SLGL) 
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-dail...
Website: http://www.sol-gel.com
Founded: 1997
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.60
H 5.30
L 4.40
C 4.70
V 19,451
10EMA 4.70
20EMA 4.70
60EMA 4.70
120EMA 4.70
250EMA 4.70